Omeros OMER
NASDAQ OMER
$18.06 +0.76 (+4.36%)
As of: Nov 11, 2026 · 3:29 PM EST

Omeros (OMER) Price to Sales (2010 - 2026)

Updated

Omeros' Price to Sales came in at 17.84 for Q2 2026, up 482.9% from 3.06 a year earlier but down 6.4% from the prior quarter.

Analysis

Omeros (OMER) Price to Sales (2010 - 2026) Analysis & Trends

For FY2020, Omeros' Price to Sales was 11.94, up 74.8% from FY2019.

  • Going back by year, Price to Sales was 6.83 in FY2019 (-62.6%), 18.28 in FY2018 (+26.5%), 14.45 in FY2017 (+38.3%) and 10.44 in FY2016 (-76.4%).
  • The five-year range for quarterly Price to Sales is 3.06 (Q2 2025) to 19.06 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Omeros 234.42 Mn -206.99 Mn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.52
Mar 31, 2026 6.34
Dec 31, 2025 18.36
Sep 30, 2025 3.43
Jun 30, 2024 4.03
Mar 31, 2024 0.93
Dec 31, 2023 0.57
Dec 31, 2021 0.79
Sep 30, 2021 2.06
Jun 30, 2021 2.32
Mar 31, 2021 3.38
Dec 31, 2020 2.62
Sep 30, 2020 1.42
Jun 30, 2020 1.99
Mar 31, 2020 1.60
Dec 31, 2019 1.71
Sep 30, 2019 2.01
Jun 30, 2019 2.57
Mar 31, 2019 4.25
Dec 31, 2018 4.57
API Access

Omeros Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=OMER&period=max&api_key=YOUR_API_KEY